LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma. (April 2016)

Record Type:
Journal Article
Title:
LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma. (April 2016)
Main Title:
LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma
Authors:
Bergeat, D.
Fautrel, A.
Turlin, B.
Merdrignac, A.
Rayar, M.
Meunier, B.
Clement, B.
Boudjema, K.
Coulouarn, C.
Sulpice, L.
Abstract:
Is Part Of:
HPB. Volume 18(2016)Supplement 2
Journal:
HPB
Issue:
Volume 18(2016)Supplement 2
Issue Display:
Volume 18, Issue 2 (2016)
Year:
2016
Volume:
18
Issue:
2
Issue Sort Value:
2016-0018-0002-0000
Page Start:
e863
Page End:
Publication Date:
2016-04
Subjects:
Liver -- Diseases -- Periodicals
Biliary tract -- Diseases -- Periodicals
Pancreas -- Diseases -- Periodicals
616.362005
Journal URLs:
https://www.journals.elsevier.com/hpb/ ↗
http://www.hpbonline.org/current ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1477-2574 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1016/j.hpb.2016.01.490 ↗
Languages:
English
ISSNs:
1365-182X
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 4335.262340
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
5674.xml